Today: 7 February 2026
Subscribe
Browse Category

Market Outlook News 27 June 2025 - 12 November 2025

GlobalFoundries (GFS) beats Q3 estimates, nudges Q4 outlook above Street; Dresden capacity expansion wins fresh approval — Nov. 12, 2025

GlobalFoundries (GFS) beats Q3 estimates, nudges Q4 outlook above Street; Dresden capacity expansion wins fresh approval — Nov. 12, 2025

Earnings: what stood out GlobalFoundries posted $1.688B in Q3 revenue, with IFRS EPS at $0.44 and non‑IFRS EPS at $0.41. Margins improved both sequentially and year over year: IFRS gross margin 24.8% (non‑IFRS 26.0%), IFRS operating margin 11.6% (non‑IFRS 15.4%). The company also generated $595M in operating cash flow and ended the quarter with $4.2B in cash, cash equivalents and marketable securities. Management highlighted the fourth consecutive quarter of year‑over‑year revenue growth in Automotive and Communications Infrastructure & Data Center end markets. GlobeNewswire Guidance: slightly above consensus, with margin expansion For Q4 FY2025, GF guided to $1.80B ± $25M in
12 November 2025
···
USD/CHF Today (10.11.2025): Dollar–Franc Steady Near 0.8060 As Washington Funding Hopes Rise — Outlook & Forecast

USD/CHF Today (10.11.2025): Dollar–Franc Steady Near 0.8060 As Washington Funding Hopes Rise — Outlook & Forecast

Summary (TL;DR) Where USD/CHF Stands Now (10 November 2025) Takeaway: Price action is calm and boxed inside the 0.80–0.81 band as broader dollar moves pause and CHF retains a low‑inflation, low‑rate premium. Reuters What’s Moving USD/CHF Today The Swiss Side: Rates, Inflation & Policy Stance Implication: With inflation near the bottom of the SNB’s 0–2% range, there’s little domestic pressure to tighten; equally, ultra‑low inflation leaves the SNB comfortable with a steady‑hand stance unless CHF strength turns disorderly. SNB The U.S. Side: Fed Path & This Week’s Catalyst USD/CHF Technical & Trading Picture (No‑Chart) Structure: Sideways bias inside 0.8000–0.8100 since
10 November 2025
·
Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Financing & balance sheet: euro notes + tender offer Bristol‑Myers Squibb priced €5 billion in senior unsecured notes across five tranches — €750M 2030 (2.973%), €1.15B 2033 (3.363%), €1.15B 2038 (3.857%), €750M 2045 (4.289%), and €1.2B 2055 (4.581%) — with closing anticipated Nov. 10, 2025. The notes are guaranteed by Bristol‑Myers Squibb Company. Bristol Myers Squibb News Proceeds, plus about $3B in cash, are earmarked to fund BMS’s cash tender offers for multiple outstanding dollar notes. The offers expire Dec. 3, 2025 (early tender Nov. 17), with maximum aggregate purchase prices of $4B (Pool 1) and $3B (Pool 2) excluding
9 November 2025
····
XRP Price on Nov 3, 2025: $2.40 Shake-Up, ETF Frenzy & Bold Forecasts Ahead

XRP Price Today, Nov 7, 2025: $2.36 Holds as Ripple Lands $500M at $40B Valuation — Outlook, Catalysts, and Key Levels

Updated November 7, 2025 Key Takeaways (TL;DR) XRP Price Today (Nov 7, 2025) As of publication, XRP changes hands near $2.36, rebounding from a session low around $2.16 and shy of today’s intraday high near $2.37. Liquidity has been uneven amid broader crypto risk aversion this week. Intraday, XRP remained tethered to a high‑traffic $2.20–$2.30 zone after a support break earlier in the session pushed price action toward the $2.20 “defense” area that traders have been watching since the first week of November. CoinDesk Across majors, the tone is still tentative: Bitcoin hovering near $102K and altcoins fading into rallies
7 November 2025
····
JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

Date: Nov. 6, 2025 Key takeaways What’s new today (Nov. 6) Following Monday’s earnings release, JELD‑WEN confirmed it will shed ~850 positions across North America and corporate functions and is reviewing strategic alternatives for its Europe segment. The workforce actions, slated to be completed by the end of 2025, are part of a broader cost‑reset amid weaker demand and price‑cost pressure. Q4 Capital Charlotte’s local press reports the reductions will include positions in the Charlotte area, adding a regional dimension to the restructuring at the company’s headquarters. Charlotte Observer The numbers: Q3 at a glance The Associated Press likewise summarized
6 November 2025
···
Apollo Global Management Stock Soars on Earnings Beat – Big Deals and 2025 Outlook

Apollo Global Management Stock Soars on Earnings Beat – Big Deals and 2025 Outlook

Current Stock Price & Recent Performance (2025) Apollo’s stock has experienced significant swings in 2025. After a strong 2023, APO entered 2025 near its highs but has pulled back sharply amid market volatility and higher interest rates, falling roughly one-quarter from January levelsreuters.com. On November 4, 2025, shares surged in response to Apollo’s earnings beat – up about 6–7% intraday to the mid-$130sstockanalysis.com. This pop reflects renewed investor optimism following the earnings surprise. Even with that rebound, Apollo’s stock is still well below its 52-week high of $189 and under its 200-day moving average (~$136)marketbeat.com, indicating it hasn’t yet regained
4 November 2025
·····
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Stock Price and Recent Performance Pfizer’s stock has languished in 2025 despite a rising broader market. At ~$24.65, PFE is roughly flat since January and far below its 2021 peak (~$50)sharewise.com. In the past three years, the shares have tumbled about 50% as the company’s COVID-fueled revenue boom faded and investors braced for patent expirationssharewise.com. By mid-2025, Pfizer traded near multi-year lows (around $23), though it bounced off those lows in early October after positive news on earnings and policy. Notably, Pfizer’s stock surged ~15% at the end of Q3 (from ~$23.85 on Sept. 29 to ~$27.37 by Oct. 3statmuse.comstatmuse.com)
3 November 2025
····
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Stock Price Skyrockets on Acquisition News Shares of XORTX Therapeutics Inc. (NASDAQ: XRTX) surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per share (up from around $0.86 the prior day)ragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level. This rally was accompanied by an explosion in
17 October 2025
···
Lithium Americas Stock Skyrockets on U.S. Stake Rumor – EV Boom, Lithium Prices & 2025 Outlook

Lithium Americas Stock Skyrockets on U.S. Stake Rumor – EV Boom, Lithium Prices & 2025 Outlook

Latest Stock Performance: LAC’s Wild Ride in Late September 2025 Lithium Americas stock went on a roller-coaster in late September 2025. On September 24, shares skyrocketed in pre-market trading after a Reuters report revealed that the U.S. government is considering taking an equity stake in the company Reuters. LAC opened around $5.13 (up ~67%) that morning – a dramatic jump from roughly $3 the day before Reuters. In after-hours trading the prior evening, the stock had already leapt as high as $5.54 on the news Reuters. This marked a sharp reversal from September 23, when LAC had slid nearly 7% amid broader market weakness and uncertainty over
24 September 2025
····
Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

In 2024 the value of new industrial robot installations reached $16.5 billion, with over 4.28 million robots operating in factories worldwide. Asia accounted for 70% of new robot installations in 2023, with China alone representing 51% of 2023 installations. In 2025 robotics is being transformed by AI, with analytical AI, Physical AI simulators like NVIDIA’s Omniverse and Isaac, and Generative AI driving a “ChatGPT moment” for physical robots. Humanoid robots like Tesla’s Optimus target about $20,000 per unit, with forecasts calling for about 40,000 units by 2032 and a $38–66 billion market by 2035. In 2024 Intuitive Surgical’s da Vinci
28 June 2025
··
Global Semiconductor Industry Trends and 2025 Outlook: AI Boom, Advanced Nodes, and Geopolitics (Report: June 27th, 2025)

Global Semiconductor Industry Trends and 2025 Outlook: AI Boom, Advanced Nodes, and Geopolitics (Report: June 27th, 2025)

Global semiconductor revenue reached $626 billion in 2024, up 18.1% from 2023, with Gartner projecting about $705 billion in 2025. Data-center AI chip sales rose to $112 billion in 2024, up from $64.8 billion in 2023, making generative AI workloads the second-largest semiconductor market after smartphones. Memory revenue jumped about 72% in 2024 and accounted for roughly 25% of total market, with HBM revenues expected to grow 66% in 2025 to $19.8 billion. TSMC’s 2nm node (N2) is in pilot production with high-volume manufacturing planned for 2H 2025, aiming for about 50,000 wafer starts per month by end-2025, with Apple
27 June 2025
····
1 … 23 24 25 26

Stock Market Today

Singapore Airlines stock dips as supply-chain “new norm” raises cost focus before SGX reopens

Singapore Airlines stock dips as supply-chain “new norm” raises cost focus before SGX reopens

7 February 2026
Singapore, Feb 7, 2026, 15:06 (SGT) — Market closed Singapore Airlines Ltd shares slipped on Friday, ending at S$6.70, as investors weighed fresh warnings that aircraft parts shortages are becoming a longer-running drag on airline costs. (Yahoo Finance) The pressure point is maintenance and reliability, not bookings. Executives at this week’s Singapore Airshow said supply delays have become a “new norm”, and Scoot chief executive Leslie Thng said the airline has had to “secure more spare engines at our own expense” to limit disruption. IATA said global passenger traffic in 2025 was about 9.3% above 2019 levels and forecast another
CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
Go toTop